- Echeverri, Danilo
- Calucho, Enric
- Marrugo-Ramírez, José
- Álvarez-Diduk, Ruslan
- Orozco, Jahir
- Merkoçi, Arben
Nanostructured electrochemical biosensors have ushered in a new era of diagnostic precision, offering enhanced sensitivity and specificity for clinical biomarker detection. Among them, capacitive biosensing enables ultrasensitive label-free detection of multiple molecular targets. However, the complexity and cost associated with conventional fabrication methods of nanostructured platforms hinder the widespread adoption of these devices. This study introduces a capacitive biosensor that leverages laser-engraved reduced graphene oxide (rGO) electrodes decorated with gold nanoparticles (AuNPs). The fabrication involves laser-scribed GO-Au3+ films, yielding rGO-AuNP electrodes, seamlessly transferred onto a PET substrate via a press-stamping methodology. These electrodes have a remarkable affinity for biomolecular recognition after being functionalized with specific bioreceptors. For example, initial studies with human IgG antibodies confirm the detection capabilities of the biosensor using electrochemical capacitance spectroscopy. Furthermore, the biosensor can quantify CA-19-9 glycoprotein, a clinical cancer biomarker. The biosensor exhibits a dynamic range from 0 to 300 U mL−1, with a limit of detection of 8.9 U mL−1. Rigorous testing with known concentrations of a pretreated CA-19-9 antigen from human fluids confirmed their accuracy and reliability in detecting the glycoprotein. This study signifies notable progress in capacitive biosensing for clinical biomarkers, potentially leading to more accessible and cost-effective point-of-care solutions., The ICN2 is funded by the CERCA programme/Generalitat de Catalunya. The ICN2 is supported by the Severo Ochoa Centres of Excellence program, Grant CEX2021-001214-S, funded by MCIN/AEI/10.13039.501100011033. Minciencias partially funded the work through the project Cod. 111593092980. This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 881603. Views and opinions expressed are, however, those of the author(s) only and do not necessarily reflect those of the European Union. The European Union can not be held responsible for them. JO thanks support from The University of Antioquia and the Max Planck Society through the cooperation agreement 566–1, 2014. We thank The Ruta N complex for hosting the Max Planck Tandem Groups. E. Calucho acknowledges Ministerio de Ciencia e Innovación of Spain and Fondo Social Europeo for the Fellowship PRE2018-084856 awarded under the call “Ayudas para contratos predoctorales para la formación de doctores, Subprograma Estatal de Formación del Programa Estatal de Promoción del Talento y su Empleabilidad en I+D+i”, under the framework of “Plan Estatal de Investigación Científica y Técnica y de Innovación 2017–2020”. E. Calucho also acknowledges Universitat Autònoma de Barcelona (UAB) for the support and the possibility of performing this work within the framework of the Biotechnology PhD Programme., With funding from the Spanish government through the "Severo Ochoa Centre of Excellence" accreditation (CEX2021-001214-S)., Peer reviewed